I touted Allergan at 52.75 on Thursday, and it closed today at 55.55. Tonight the WSJ touted AGN as a takeover target:
On Monday Allergan's shares rose 4%, sparking fresh questions about whether a deal could be in development. But with a market cap of $17 billion, some might consider the California-based Allergan a midsize target.
As advertised!!
No comments:
Post a Comment